C

Curative Biotechnology Inc
OTC:CUBT

Watchlist Manager
Curative Biotechnology Inc
OTC:CUBT
Watchlist
Price: 0.0149 USD Market Closed
Market Cap: 13.7m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

CUBT latest financial reports are more than 8 years old.
CUBT doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of CUBT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CUBT Relative Value
Base Case
Not Available
C
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-6.2
Industry
16
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-9.4
Median 5Y
-15.7
Industry
9.7
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-23.4
Median 5Y
-38.9
Industry
13
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-12.2
Median 5Y
-14.9
Industry
1.6
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3.1
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.4
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-8
Industry
10.3
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-4.9
Median 5Y
-8
Industry
12.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-10
Median 5Y
-16.2
Industry
10.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-15.5
Industry
11.6
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-70.2
Median 5Y
-49.5
Industry
1.5
More Details

Multiples Across Competitors

CUBT Competitors Multiples
Curative Biotechnology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Curative Biotechnology Inc
OTC:CUBT
13.7m USD 0 -3.3 -4.4 -4.4
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR 0 0 0 0
CA
Australian Goldfields Ltd
OTC:GRXXF
2.7T USD 0 -7 705 793.7 -7 705 790.1 -7 705 790.1
US
GE Vernova LLC
NYSE:GEV
126.7B USD 0 0 0 0
IN
SAB Industries Ltd
BSE:539112
2.7B INR 4.9 -4.1 56.3 59.4
US
China Industrial Group Inc
OTC:CIND
92.2B USD 267.9 3 063.4 2 603.8 2 695
NL
Nepi Rockcastle NV
JSE:NRP
82.6B Zac 0 0 0 0
US
Coupang Inc
F:788
43B EUR 1.6 189.4 43.5 79.9
US
CoreWeave Inc
NASDAQ:CRWV
47.7B USD 0 0 0 0
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
500.4T IDR 14.9 83.6 41.4 41.4
CH
Galderma Group AG
SIX:GALD
24.3B CHF 0 0 0 0
P/S Multiple
Revenue Growth P/S to Growth
US
C
Curative Biotechnology Inc
OTC:CUBT
Average P/S: 72.3
Not Available 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
Not Available N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
9%
N/A
IN
S
SAB Industries Ltd
BSE:539112
4.9
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
267.9
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-4%
N/A
US
Coupang Inc
F:788
1.6
14%
0.1
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
101%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
14.9
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
14%
N/A
P/E Multiple
Earnings Growth PEG
US
C
Curative Biotechnology Inc
OTC:CUBT
Average P/E: 1 112.2
Negative Multiple: -3.3 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
Negative Multiple: -7 705 793.7 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
40%
N/A
IN
S
SAB Industries Ltd
BSE:539112
Negative Multiple: -4.1 N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
3 063.4
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
-5%
N/A
US
Coupang Inc
F:788
189.4
126%
1.5
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available N/A N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
83.6
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
75%
N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Curative Biotechnology Inc
OTC:CUBT
Average EV/EBITDA: 686.2
Negative Multiple: -4.4 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
Negative Multiple: -7 705 790.1 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
44%
N/A
IN
S
SAB Industries Ltd
BSE:539112
56.3
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
2 603.8
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
7%
N/A
US
Coupang Inc
F:788
43.5
55%
0.8
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
119%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
41.4
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
23%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Curative Biotechnology Inc
OTC:CUBT
Average EV/EBIT: 718.9
Negative Multiple: -4.4 		N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
Negative Multiple: -7 705 790.1 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
78%
N/A
IN
S
SAB Industries Ltd
BSE:539112
59.4
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
2 695
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
12%
N/A
US
Coupang Inc
F:788
79.9
83%
1
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
136%
N/A
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
41.4
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
35%
N/A

See Also

Summary
CUBT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CUBT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CUBT stock valuation using valuation multiples.
Wall Street Estimates
CUBT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CUBT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 257,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.